Crohn's disease-related 'gastrocnemius myalgia syndrome' successfully treated with infliximab: A case report

CONCLUSION: The GMS represent a rare CD-associated inflammatory myopathy for which anti-tumour necrosis factor-α therapy might be considered as an effective therapeutic option.PMID:35317272 | PMC:PMC8891723 | DOI:10.3748/wjg.v28.i7.755

Source: World Journal of Gastroenterology : WJG - March 23, 2022 Category: Gastroenterology Authors: Julien Catherine Hazim Kadhim Fr édéric Lambot Claire Liefferinckx Virginie Meurant Lukas Otero Sanchez Source Type: research